The developers believe the test will help drive the development of new therapeutics for endometriosis
The round brings the company's total funding to US$22.3m, underscoring the need to rebuild US maternity care services
Phexxi will be the first and only hormone-free contraceptive offered by Favor
The clinic has previously raised €17m in funding to expand to Spain, Germany and Italy
Following the Supreme Court's decision to end the right to abortion, US care providers had to find new ways to deliver critical services
The designation seeks to streamline the development of new agents with potential to treat serious or life-threatening diseases
The cooperative will offer access to fertility care for more than 60 American employers
Over 70 per cent of women have delayed getting a Pap test, the US medtech company BD has found
FemCath is the first FDA-cleared intrauterine catheter that allows for selective evaluation of a fallopian tube with contrast, say developers
The US$8m investment will grant the company the option to acquire the US start-up, Claria Medical
